Mild to Moderate Alzheimer Dementia with Insufficient Neuropathological Changes

被引:97
作者
Serrano-Pozo, Alberto [1 ,2 ,10 ]
Qian, Jing [3 ]
Monsell, Sarah E. [4 ,5 ]
Blacker, Deborah [1 ,6 ,7 ]
Gomez-Isla, Teresa [1 ,2 ]
Betensky, Rebecca A. [1 ,7 ]
Growdon, John H. [1 ,2 ]
Johnson, Keith A. [1 ,2 ]
Frosch, Matthew P. [1 ,8 ]
Sperling, Reisa A. [1 ,9 ]
Hyman, Bradley T. [1 ,2 ]
机构
[1] Massachusetts Alzheimer Dis Res Ctr, Charlestown, MA 02129 USA
[2] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
[3] Univ Massachusetts, Div Biostat & Epidemiol, Amherst, MA 01003 USA
[4] Univ Washington, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA
[5] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[6] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA
[7] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[8] Massachusetts Gen Hosp, CS Kubik Lab Neuropathol, Boston, MA 02114 USA
[9] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA
[10] Univ Iowa Hosp & Clin, Dept Neurol, Iowa City, IA 52242 USA
关键词
NATIONAL INSTITUTE; DISEASE; PET; AUTOPSY;
D O I
10.1002/ana.24125
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recently, approximate to 16% of participants in an anti-A passive immunotherapy trial for mild-to-moderate Alzheimer disease (AD) had a negative baseline amyloid positron emission tomography (PET) scan. Whether they have AD or are AD clinical phenocopies remains unknown. We examined the 2005-2013 National Alzheimer's Coordinating Center autopsy database and found that approximate to 14% of autopsied subjects clinically diagnosed with mild-to-moderate probable AD have no or sparse neuritic plaques, which would expectedly yield a negative amyloid PET scan. More than half of these A-negative subjects have low neurofibrillary tangle Braak stages. These findings support the implementation of a positive amyloid biomarker as an inclusion criterion in future anti-A drug trials. Ann Neurol 2014;75:597-601
引用
收藏
页码:597 / 601
页数:5
相关论文
共 19 条
[1]  
[Anonymous], 1997, Neurobiol Aging, V18, pS1
[2]   Molecular imaging with Pittsburgh compound B confirmed at autopsy - A case report [J].
Bacskai, Brian J. ;
Frosch, Matthew P. ;
Freeman, Stefanie H. ;
Raymond, Scott B. ;
Augustinack, Jean C. ;
Johnson, Keith A. ;
Irizarry, Michael C. ;
Klunk, William E. ;
Mathis, Chester A. ;
DeKosky, Steven T. ;
Greenberg, Steven M. ;
Hyman, Bradley T. ;
Growdon, John H. .
ARCHIVES OF NEUROLOGY, 2007, 64 (03) :431-434
[3]   Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study [J].
Barthel, Henryk ;
Gertz, Hermann-Josef ;
Dresel, Stefan ;
Peters, Oliver ;
Bartenstein, Peter ;
Buerger, Katharina ;
Hiemeyer, Florian ;
Wittemer-Rump, Sabine M. ;
Seibyl, John ;
Reininger, Cornelia ;
Sabri, Osama .
LANCET NEUROLOGY, 2011, 10 (05) :424-435
[4]   Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010 [J].
Beach, Thomas G. ;
Monsell, Sarah E. ;
Phillips, Leslie E. ;
Kukull, Walter .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (04) :266-273
[5]   The National Alzheimer's Coordinating Center (NACC) database: The uniform data set [J].
Beekly, Duane L. ;
Ramos, Erin M. ;
Lee, William W. ;
Deitrich, Woodrow D. ;
Jacka, Mary E. ;
Wu, Joylee ;
Hubbard, Janene L. ;
Koepsell, Thomas D. ;
Morris, John C. ;
Kukull, Walter A. .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2007, 21 (03) :249-258
[6]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[7]  
Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4
[8]   National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease [J].
Hyman, Bradley T. ;
Phelps, Creighton H. ;
Beach, Thomas G. ;
Bigio, Eileen H. ;
Cairns, Nigel J. ;
Carrillo, Maria C. ;
Dickson, Dennis W. ;
Duyckaerts, Charles ;
Frosch, Matthew P. ;
Masliah, Eliezer ;
Mirra, Suzanne S. ;
Nelson, Peter T. ;
Schneider, Julie A. ;
Thal, Dietmar Rudolf ;
Thies, Bill ;
Trojanowski, John Q. ;
Vinters, Harry V. ;
Montine, Thomas J. .
ALZHEIMERS & DEMENTIA, 2012, 8 (01) :1-13
[9]   Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease [J].
Ikonomovic, Milos D. ;
Klunk, William E. ;
Abrahamson, Eric E. ;
Mathis, Chester A. ;
Price, Julie C. ;
Tsopelas, Nicholas D. ;
Lopresti, Brian J. ;
Ziolko, Scott ;
Bi, Wenzhu ;
Paljug, William R. ;
Debnath, Manik L. ;
Hope, Caroline E. ;
Isanski, Barbara A. ;
Hamilton, Ronald L. ;
DeKosky, Steven T. .
BRAIN, 2008, 131 :1630-1645
[10]   Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study [J].
Ikonomovic, Milos D. ;
Abrahamson, Eric E. ;
Price, Julie C. ;
Hamilton, Ronald L. ;
Mathis, Chester A. ;
Paljug, William R. ;
Debnath, Manik L. ;
Cohen, Anne D. ;
Mizukami, Katsuyoshi ;
DeKosky, Steven T. ;
Lopez, Oscar L. ;
Klunk, William E. .
ACTA NEUROPATHOLOGICA, 2012, 123 (03) :433-447